Benitec Biopharma Inc — Cash Flow (NASDAQ:BNTC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 12.8 M15.9 M18 M19.4 M23.6 M 18.4 M Cash from investing activities 221 K13 K1 000179 K18 K 17 K Cash from financing activities 22.52 M22.52 M16.02 M68.03 M70.48 M 129.19 M Free cash flow 12.58 M15.89 M18 M19.22 M23.58 M 18.4 M

News

Benitec BioPharma stock rating maintained on gene therapy data

Benitec to present BB-301 gene therapy study results in March

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade

Citizens reiterates Market Outperform rating on Benitec BioPharma stock

Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target

Benitec’s gene therapy shows durable results in OPMD patients

Monday’s Insider Moves: Dolphin CEO’s Big Bet Amid Notable Sells

Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?

Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys

Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972